The price of rotavirus vaccines for newborns is expected to increase altogether, with GSK also deciding to increase its supply price of ‘Rotarix’ after MSD’s price hike on ‘RotaTeq.’

Kwang Dong Pharmaceutical, the company in charge of the domestic supply of GSK’s Rotarix, recently sent a notice to clinics and hospitals on the decision to increase Rotarix’s supply price. The price will increase approximately 12% from the current late-70,000 won range to reach the mid-80,000 won range per dose (VAT included). The change in Rotarix’s supply price will be applied from May 1st.

Prior to GSK, MSD had also raised the price of its rotavirus vaccine RotaTeq by 17%. With th